Professor Bart Vanhaesebroeck

Prof. Vanhaesebroeck is an expert in the biology of the isoforms of PI3K, and their involvement in diseases such as cancer and inflammation. He discovered the p110δ isoform of PI3K and has assisted in several PI3K drug development programs within pharma and biotech. He is a co-founder of Activiomics (London, UK) and is an elected member of the UK Academy of Medical Sciences and the European Molecular Biology Organisation.